# PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pi3k-inhibitors-in-advanced-breast-cancer-the-past-the-present-new-challenges/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paola Fuso,Margherita Muratore,Tatiana D’Angelo,Ida Paris,Luisa Carbognin,Giordana Tiberi,Francesco Pavese,Simona Duranti,Armando Orlandi,Giampaolo Tortora,Giovanni Scambia,Alessandra Fabi |
| Citations | 49 |
| DOI | 10.3390/cancers14092161 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2072-6694/14/9/2161/pdf?version=1650973210 |
| OpenAlex ID | https://openalex.org/W4225003865 |
| PMID | 35565291 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Francesco Pavese](https://scholariq.org/researchers/francesco-pavese/)

## Paper journal

- [Cancers](https://scholariq.org/journals/cancers/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.